198 related articles for article (PubMed ID: 37398677)
1. Anti-complement 5 antibody ameliorates antibody-mediated rejection after liver transplantation in rats.
Tajima T; Hata K; Kusakabe J; Miyauchi H; Badshah JS; Kageyama S; Zhao X; Kim SK; Tsuruyama T; Kirchner VA; Watanabe T; Uemoto S; Hatano E
Front Immunol; 2023; 14():1186653. PubMed ID: 37398677
[TBL] [Abstract][Full Text] [Related]
2. Antibodies against complement component C5 prevent antibody-mediated rejection after lung transplantation in murine orthotopic models with skin-graft-induced pre-sensitization.
Shiina Y; Suzuki H; Hata A; Kaiho T; Matsumoto H; Toyoda T; Sakairi Y; Wada H; Motohashi S; Yoshino I
Gen Thorac Cardiovasc Surg; 2022 Dec; 70(12):1032-1041. PubMed ID: 35767165
[TBL] [Abstract][Full Text] [Related]
3. Novel Complement C5 Small-interfering RNA Lipid Nanoparticle Prolongs Graft Survival in a Hypersensitized Rat Kidney Transplant Model.
Ishigooka H; Katsumata H; Saiga K; Tokita D; Motoi S; Matsui C; Suzuki Y; Tomimatsu A; Nakatani T; Kuboi Y; Yamakawa T; Ikeda T; Ishii R; Imai T; Takagi T; Tanabe K
Transplantation; 2022 Dec; 106(12):2338-2347. PubMed ID: 35749284
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience.
Zheng J; Xue W; Qing X; Jing X; Hou J; Tian X; Guo Q; He X; Cai J
Clin Transpl; 2014; ():223-30. PubMed ID: 26281149
[TBL] [Abstract][Full Text] [Related]
5. Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients.
Stegall MD; Diwan T; Raghavaiah S; Cornell LD; Burns J; Dean PG; Cosio FG; Gandhi MJ; Kremers W; Gloor JM
Am J Transplant; 2011 Nov; 11(11):2405-13. PubMed ID: 21942930
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for antibody-mediated rejection in ABO blood-type incompatible and donor-specific antibody-positive liver transplantation.
Tajima T; Hata K; Haga H; Kusakabe J; Kageyama S; Yurugi K; Hishida R; Zhao X; Nishikori M; Nagao M; Takaori-Kondo A; Uemoto S; Hatano E
Liver Transpl; 2023 Jul; 29(7):711-723. PubMed ID: 36749821
[TBL] [Abstract][Full Text] [Related]
7. Report of the inefficacy of eculizumab in two cases of severe antibody-mediated rejection of renal grafts.
Burbach M; Suberbielle C; Brochériou I; Ridel C; Mesnard L; Dahan K; Rondeau E; Hertig A
Transplantation; 2014 Nov; 98(10):1056-9. PubMed ID: 24839895
[TBL] [Abstract][Full Text] [Related]
8. Detection of Complement-binding Donor-specific Antibodies, Not IgG-antibody Strength Nor C4d Status, at Antibody-mediated Rejection Diagnosis Is an Independent Predictor of Kidney Graft Failure.
Malheiro J; Santos S; Tafulo S; Dias L; Martins S; Fonseca I; Almeida M; Pedroso S; Beirão I; Castro-Henriques A; Cabrita A
Transplantation; 2018 Nov; 102(11):1943-1954. PubMed ID: 29757900
[TBL] [Abstract][Full Text] [Related]
9. Desensitization and Prevention of Antibody-Mediated Rejection in Vascularized Composite Allotransplantation by Syngeneic Hematopoietic Stem Cell Transplantation.
Wang HD; Fidder SAJ; Miller DT; Furtmüller GJ; Ahmadi AR; Nägele F; Lopez J; Quan A; Budihardjo J; Lough DM; Akpinarli B; Etra JW; Vasilic D; Raimondi G; Lee WPA; Montgomery RA; Sun Z; Brandacher G
Transplantation; 2018 Apr; 102(4):593-600. PubMed ID: 29298238
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of pre-sensitization-related acute antibody-mediated rejection in a rat model of orthotopic liver transplantation.
Mang Y; Zhang S; Zhao J; Ran J; Zhao Y; Li L; Gao Y; Li W; Chen G; Ma J; Li L; Bao F
Ann Transl Med; 2022 Oct; 10(19):1066. PubMed ID: 36330418
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic Effects and Functional Mechanism of Intravenous Immunoglobulin in Preclinical Rat Renal Transplant Model of Antibody-Mediated Rejection.
Yamanaka K; Imamura R; Nakazawa S; Kato T; Kakuta Y; Abe T; Okumi M; Nonomura N
Transplant Proc; 2020; 52(6):1901-1905. PubMed ID: 32362462
[TBL] [Abstract][Full Text] [Related]
12. Significance of complement split product C4d in ABO-compatible liver allograft: diagnosing utility in acute antibody mediated rejection.
Ali S; Ormsby A; Shah V; Segovia MC; Kantz KL; Skorupski S; Eisenbrey AB; Mahan M; Huang MA
Transpl Immunol; 2012 Jan; 26(1):62-9. PubMed ID: 21907804
[TBL] [Abstract][Full Text] [Related]
13. C1q Donor-Specific Antibody Associates with Post-transplant Biopsy Findings in Highly- Sensitized Kidney Transplant Recipients.
Kuppachi S; Holanda D; Gallegos S; Field EH
Clin Transpl; 2016; 32():127-134. PubMed ID: 28564530
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Spleen Tyrosine Kinase Reduces Renal Allograft Injury in a Rat Model of Acute Antibody-Mediated Rejection in Sensitized Recipients.
Ramessur Chandran S; Han Y; Tesch GH; Di Paolo J; Mulley WR; Kanellis J; Ma FY; Nikolic-Paterson DJ
Transplantation; 2017 Aug; 101(8):e240-e248. PubMed ID: 28594748
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic Contribution of Donor-Specific Antibody Characteristics to Uncover Late Silent Antibody-Mediated Rejection-Results of a Cross-Sectional Screening Study.
Eskandary F; Bond G; Kozakowski N; Regele H; Marinova L; Wahrmann M; Kikić Ž; Haslacher H; Rasoul-Rockenschaub S; Kaltenecker CC; König F; Hidalgo LG; Oberbauer R; Halloran PF; Böhmig GA
Transplantation; 2017 Mar; 101(3):631-641. PubMed ID: 27120452
[TBL] [Abstract][Full Text] [Related]
16. Acute Antibody-mediated rejection in liver transplantation: Impact and applicability of the Banff working group on liver allograft pathology 2016 criteria.
Maurice JB; Nwaogu A; Gouda M; Shaw O; Sanchez-Fueyo A; Zen Y
Hum Pathol; 2022 Sep; 127():67-77. PubMed ID: 35728694
[TBL] [Abstract][Full Text] [Related]
17. Upfront use of eculizumab to treat early acute antibody-mediated rejection after kidney allotransplantation and relevance for xenotransplantation.
Schwotzer N; Paganetti G; Barchi M; Perrottet N; Aubert V; Sadallah S; Rotman S; Venetz JP; Matter M; Golshayan D; Pascual M
Xenotransplantation; 2020 Jul; 27(4):e12630. PubMed ID: 32698246
[TBL] [Abstract][Full Text] [Related]
18. A Model of Acute Antibody-Mediated Renal Allograft Rejection in the Sensitized Rata.
Chandran SR; Mulley WR; Kanellis J; Nikolic-Paterson DJ; Ma FY
Exp Clin Transplant; 2018 Jun; 16(3):294-300. PubMed ID: 28760115
[TBL] [Abstract][Full Text] [Related]
19. De novo HLA Class II antibodies are associated with the development of chronic but not acute antibody-mediated rejection after liver transplantation - a retrospective study.
Kovandova B; Slavcev A; Honsova E; Erhartova D; Skibova J; Viklicky O; Trunecka P
Transpl Int; 2020 Dec; 33(12):1799-1806. PubMed ID: 33020979
[TBL] [Abstract][Full Text] [Related]
20. Treatment of donor-specific anti-HLA antibodies-mediated rejection after liver transplantation: A French nationwide retrospective study.
Dumortier J; Conti F; Hiriart JB; Dharancy S; Duvoux C; Besch C; Houssel-Debry P; Latournerie M; Chermak F; Meszaros M; Pageaux GP; Radenne S; Boillot O; Hardwigsen J; Kounis I; Kamar N; Saliba F; Erard D; Del Bello A
Liver Transpl; 2023 Dec; 29(12):1313-1322. PubMed ID: 37367954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
